Hydrophobic Tetracycline Immobilized in Fibrous Hyaluronan Regulates Adhesive Collagen‐Based Hydrogel Stability for Infected Wound Healing
Source abstract
Abstract
Abstract Collagen‐based hydrogels have a significant impact on wound healing, but they suffer from structural instability and bacterial invasion in infected wounds. Here, electrospun nanofibers of esterified hyaluronan (HA‐Bn/T) are developed to immobilize the hydrophobic antibacterial drug tetracycline by π–π stacking interaction. Dopamine‐modified hyaluronan and HA‐Bn/T are employed simultaneously to stabilize the structure of collagen‐based hydrogel by chemically interweaving the collagen fibril network and decreasing the rate of collagen degradation. This renders it injectable for in situ gelation, with suitable skin adhesion properties and long‐lasting drug release capability. This hybridized interwoven hydrogel promotes the proliferation and migration of L929 cells and vascularization in vitro. It presents satisfactory antibacterial ability against Staphylococcus aureus and Escherichia coli. The structure also retains the functional protein environment provided by collagen fiber, inhibits the bacterial environment of infected wounds, and modulates local inflammation, resulting in neovascularization, collagen deposition, and partial follicular regeneration. This strategy offers a new solution for infected wound healing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Engineering Research Center for Biomaterials Sichuan University 29^{#} Wangjiang Road Chengdu 610064 P. R. China
College of Biomedical Engineering Sichuan University 29^{#} Wangjiang Road Chengdu Sichuan 610064 P. R. China
Center of Infectious Diseases West China Hospital of Sichuan University No. 37 GuoXue Xiang, Wuhou District Chengdu 610041 P. R. China
Funding
National Natural Science Foundation of China
References (50)
Show source-provided references
1. 10.1002/adfm.20200064410.1002/adfm.202000644 ↗
2. 10.1002/adfm.20170475710.1002/adfm.201704757 ↗
3. 10.1016/j.bioactmat.2021.06.01410.1016/j.bioactmat.2021.06.014 ↗
4. 10.1016/j.addr.2003.08.00310.1016/j.addr.2003.08.003 ↗
5. 10.1016/j.biomaterials.2017.04.04110.1016/j.biomaterials.2017.04.041 ↗
6. 10.1021/acsnano.6b0840410.1021/acsnano.6b08404 ↗
7. 10.1097/SLA.000000000000305310.1097/SLA.0000000000003053 ↗
8. 10.1016/j.bioactmat.2020.06.00510.1016/j.bioactmat.2020.06.005 ↗
9. 10.1002/adhm.20220305410.1002/adhm.202203054 ↗
10. 10.1002/adfm.20210145210.1002/adfm.202101452 ↗
11. 10.1002/advs.20170052710.1002/advs.201700527 ↗
12. 10.1021/acsami.9b2314010.1021/acsami.9b23140 ↗
13. 10.1002/smll.20210399310.1002/smll.202103993 ↗
14. 10.1002/smll.20220176610.1002/smll.202201766 ↗
15. 10.1093/cid/ciz39410.1093/cid/ciz394 ↗
16. 10.1001/jama.1984.0335015000300310.1001/jama.1984.03350150003003 ↗
17. 10.1016/j.phrs.2010.10.00710.1016/j.phrs.2010.10.007 ↗
18. 10.1016/S0161-6420(86)33570-X10.1016/S0161-6420(86)33570-X ↗
19. 10.1016/j.phrs.2011.06.01310.1016/j.phrs.2011.06.013 ↗
20. Guerra W. · Coord. Chem. Rev. · 2016 · 188 · 327
21. 10.1177/0022034587066008040110.1177/00220345870660080401 ↗
22. 10.1039/C4BM00370E10.1039/C4BM00370E ↗
23. 10.1016/j.jconrel.2021.03.03310.1016/j.jconrel.2021.03.033 ↗
24. 10.1016/j.bioactmat.2017.03.00310.1016/j.bioactmat.2017.03.003 ↗
25. 10.1016/j.cej.2020.12540510.1016/j.cej.2020.125405 ↗
26. 10.1016/j.carbpol.2021.11822410.1016/j.carbpol.2021.118224 ↗
27. Li X. · Adv. Funct. Mater. · 2023 · 33 · 2212
28. 10.1016/j.jconrel.2018.12.01410.1016/j.jconrel.2018.12.014 ↗
29. 10.7150/thno.2002810.7150/thno.20028 ↗
30. 10.1002/smll.20220552810.1002/smll.202205528 ↗
31. 10.1016/j.jece.2021.10657410.1016/j.jece.2021.106574 ↗
32. 10.1039/D0EE01723J10.1039/D0EE01723J ↗
33. 10.1002/advs.20200362710.1002/advs.202003627 ↗
34. 10.1002/adfm.20200801010.1002/adfm.202008010 ↗
35. 10.1016/j.cej.2020.12566810.1016/j.cej.2020.125668 ↗
36. 10.1016/j.compositesb.2022.11045110.1016/j.compositesb.2022.110451 ↗
37. 10.1007/s10311-018-0803-y10.1007/s10311-018-0803-y ↗
38. 10.1002/smll.20200752210.1002/smll.202007522 ↗
39. 10.1002/adfm.20210616710.1002/adfm.202106167 ↗
40. 10.1016/j.biomaterials.2018.01.05510.1016/j.biomaterials.2018.01.055 ↗
41. 10.1038/nrmicro.2017.15710.1038/nrmicro.2017.157 ↗
42. 10.1016/j.compositesb.2021.10955710.1016/j.compositesb.2021.109557 ↗
43. 10.1016/j.jcis.2021.12.01310.1016/j.jcis.2021.12.013 ↗
44. 10.1128/MMBR.65.2.232-260.200110.1128/MMBR.65.2.232-260.2001 ↗
45. 10.1002/adfm.20170570810.1002/adfm.201705708 ↗
46. 10.1002/smll.20190223210.1002/smll.201902232 ↗
47. 10.1002/smll.20230109210.1002/smll.202301092 ↗
48. 10.1016/S0142-9612(98)00042-810.1016/S0142-9612(98)00042-8 ↗
49. 10.1002/adhm.20220338710.1002/adhm.202203387 ↗
50. 10.1016/j.cej.2019.01.02810.1016/j.cej.2019.01.028 ↗